The 20 Best Shwartzman Phenomenon Doctors in New Jersey, US

Ashish Khot, MD, is a fellowship-trained physician specializing in hematology/oncology with Atlantic Medical Group (AMG). Board-certified in hematology and medical oncology by the American Board of Internal Medicine, he has clinical expertise in diagnosing and treating blood disorders including anemia, leukemia, lymphoma and cancers of various organs, particularly lung, genitourinary, gastrointestinal and thoracic malignancies.Dr. Khot embraces a patient-centric approach, educating and empowering his patients and their families to make well-informed decisions regarding their health care. He strongly believes in fostering open communication among patients, their caregivers, and all collaborating physicians, ensuring that their care remains seamlessly coordinated throughout their challenging medical journeys.After earning his medical degree at Grant Medical College in Mumbai, India, Dr. Khot performed an internal medicine residency at St. Luke’s-Roosevelt Medical Center (now called Mt. Sinai West/Morningside) in New York City. He then received specialized training in a hematology and oncology fellowship at Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY.In addition to his clinical roles, Dr. Khot is the regional medical director, eastern region at Atlantic Medical Group, overseeing multiple subspecialist clinicians and pediatric practices. He is the associate medical director for GU oncology for community oncology given his special interest in genitourinary cancer. He is a national speaker on bladder and kidney cancers. He serves on several Atlantic Health System committees, including the Overlook Medical Center Blood Bank and Transfusion Committee, as well as the Union Essex Regional Council, AMG Nomination Committee and AMG Health Equity Committee. He regularly lectures and provides teaching rotations for IM and family medicine residents and medical students at Atlantic Health System hospitals.Dr. Ashish Khot is consistently recognized as a “Top Doctor” by New Jersey Monthly magazine by his peers. He is multilingual, speaking fluent Hindi and Marathi, among other languages. Dr. Khot is a participating provider of the Atlantic Accountable Care Organization. Dr. Khot is rated as an Advanced provider by MediFind in the treatment of Shwartzman Phenomenon. His top areas of expertise are Childhood Iron Deficiency Anemia, Anemia, Iron Deficiency Anemia, and Urothelial Cancer.

Ashwin Chandar is a Hematologist and a Hematologist Oncology provider in Sewell, New Jersey. Dr. Chandar is rated as an Advanced provider by MediFind in the treatment of Shwartzman Phenomenon. His top areas of expertise are Acute Mountain Sickness, Philadelphia-Negative Chronic Myeloid Leukemia, Chronic Myelogenous Leukemia (CML), and Multiple Myeloma. Dr. Chandar is currently accepting new patients.

Charlesse Pondt-Huannou, MD, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in medical oncology and hematology by the American Board of Internal Medicine, she has more than 15 years of experience treating blood diseases and various forms of cancer. Dr. Pondt-Huannou is dedicated to providing the highest quality of care for her patients. She listens thoroughly and takes time to carefully explain everything involved in the patient’s individualized plan of care.Dr. Pondt-Huannou is an expert in the fields of breast and gynecological cancers; hematologic malignancies (myeloma and chronic leukemias and lymphomas); managing complex hematological issues in high-risk obstetric and gynecologic patients; sickle cell disease; and anemia. She is also experienced in the management of liver, bladder, colon, cervical, lung, prostate and pancreatic cancers. She joined ACOHA immediately out of fellowship in 2014.After earning her medical degree from UMDNJ New Jersey Medical School in Newark, NJ, Dr. Pondt-Huannou completed an internal medicine residency at Memorial Sloan-Kettering Cancer Center concurrent with a residency at New York-Presbyterian, Cornell Medical Center, both in New York City. She completed a hematology and oncology fellowship at Albert Einstein College/Montefiore and Jacobi medical centers and Lincoln Hospital in the Bronx, NY.Dr. Pondt-Huannou is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American Medical Association, and the National Medical Association. She also serves on numerous committees including the Sickle Cell Management Committee at Overlook Medical Center. She is a participating provider of the Atlantic Accountable Care Organization. Dr. Huannou is rated as an Advanced provider by MediFind in the treatment of Shwartzman Phenomenon. Her top areas of expertise are Childhood Iron Deficiency Anemia, Anemia, Deep Vein Thrombosis, and Myelodysplastic Syndrome (MDS).

Stephen Abo is an Oncologist in Belleville, New Jersey. Dr. Abo is rated as a Distinguished provider by MediFind in the treatment of Shwartzman Phenomenon. His top areas of expertise are Shwartzman Phenomenon, Venous Thromboembolism (VTE), Inflammatory Breast Cancer, and Angiosarcoma.

Daniel Helbig is a Hematologist and an Oncologist in Cherry Hill, New Jersey. Dr. Helbig is rated as an Advanced provider by MediFind in the treatment of Shwartzman Phenomenon. His top areas of expertise are Shwartzman Phenomenon, Venous Thromboembolism (VTE), Anemia, Thrombocytopenia, and Fasciotomy. Dr. Helbig is currently accepting new patients.

Chirag Shah is a Cardiologist in Monroe, New Jersey. Dr. Shah is rated as an Advanced provider by MediFind in the treatment of Shwartzman Phenomenon. His top areas of expertise are Heart Attack, Atrial Fibrillation, Mitral Valve Regurgitation, and Coronary Heart Disease. Dr. Shah is currently accepting new patients.

Ashish Ashvin Shah, DO, MSc, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in medical oncology and hematology by the American Board of Internal Medicine, he has more than 15 years of experience treating blood diseases and various forms of cancer. Dr. Shah’s clinical interests span a wide spectrum, from acute and chronic leukemia to lymphoma, multiple myeloma, myelodysplastic disease, and various types of cancer, including lung, colorectal, breast, ovarian, and neuroendocrine tumors. He has extensive knowledge and experience in these conditions.After earning his osteopathic medicine degree from Philadelphia College of Osteopathic Medicine, Dr. Shah completed an internal medicine residency at Robert Wood Johnson University Hospital in New Brunswick, NJ. He completed a hematology and oncology fellowship also at Robert Wood Johnson. Previously, he completed a Master of Science (MSc) degree in neuroscience at Southern Connecticut State University.Prior to joining AMG, Dr. Shah served as director of leukemia/lymphoma services and co-director of the adolescent and young adult oncology program at Lehigh Valley Health Network in Bethlehem, Pennsylvania for seven years. He also served as a clinical assistant professor of medicine at the University of South Florida’s Morsani College of Medicine in Tampa. Dr. Shah joined ACOHA in 2016.Dr. Shah is a member of the American Society of Clinical Oncology, American Society of Hematology, American Osteopathic Association, and American Association of Physicians from India. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Shwartzman Phenomenon. His top areas of expertise are Iron Deficiency Anemia, Large-Cell Immunoblastic Lymphoma, Childhood Iron Deficiency Anemia, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Neil S. Nimkar, MD, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in internal medicine, medical oncology and hematology by the American Board of Internal Medicine, he is trained in all malignancies and blood disorders. His clinical interests include anemia; hematology - WBC disorders; breast, colorectal, gastrointestinal, head and neck, and urological cancer (GU); leukemia and lymphoma. Dr. Nimkar strives to provide care individualized to the needs of each patient, while incorporating the most up-to-date knowledge and using precision medicine approach in treating patients. He takes pride in delivering the highest quality of patient care.After earning his medical degree at Ross University School of Medicine in Barbados, Dr. Nimkar completed his internal medicine residency at New York-Presbyterian Brooklyn Methodist Hospital in Brooklyn, NY, where he also performed his hematology-oncology fellowship. He received awards for excellence in clinical documentation as a best patient advocate, best ambulatory resident and as a wellness warrior. Dr. Nimkar joined ACOHA in 2021 following his fellowship training.In addition to English, Dr. Nimkar is fluent in Hindi and Gujarati. He has been published several times in peer-reviewed medical journals. His recent published research includes immunotherapy in hepatocellular cancer patients with mild to severe liver dysfunction, and he conducted an extensive study analyzing causes for the overtransfusion of blood products of patients. Dr. Nimkar is a participating provider of the Atlantic Accountable Care Organization. Dr. Nimkar is rated as an Experienced provider by MediFind in the treatment of Shwartzman Phenomenon. His top areas of expertise are Familial Colorectal Cancer, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, and Melanoma.

Matthew Stuart, MD, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Dr. Stuart’s clinical interests include colorectal, pancreatic, gastrointestinal, lung, urological (GU) cancer, hematology, anemia, clotting disorders, lymphoma, multiple myeloma, and preventative care.Board-certified in internal medicine, medical oncology and hematology by the American Board of Internal Medicine, Dr. Stuart believes in treating the patient as a whole, implementing evidence-based, patient-centered, and cost-conscious care. His recent research includes evaluating race-based differences in treatment complications in patients with metastatic prostate cancer, improving vaccination rates in patients receiving chemotherapy, and providing community outreach to increase lung cancer screening and early detection.Dr. Stuart earned his medical degree at Rutgers New Jersey Medical School, Newark, NJ, where he served as director of the Student Family Health Care Center, the mini-medical school and premedical honors program, and the Institute for Public Understanding of Medicine in Action. He performed his internal medicine residency at Montefiore Medical Center, Bronx, NY, where he served on the Emergency-Internal Medicine and Resident Recruitment committees and received the Leo M. Davidoff Society Award for outstanding achievement in the teaching of medical students and a program innovation and improvement award. He remained at Montefiore to complete a fellowship in hematology/oncology, where he was named the chief hematology fellow and served on the Program Evaluation Committee. Following his fellowship training, he joined ACOHA in 2020.Fluent in conversational Spanish, Dr Stuart has presented at national and international medical conferences. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Stuart is rated as an Experienced provider by MediFind in the treatment of Shwartzman Phenomenon. His top areas of expertise are Childhood Iron Deficiency Anemia, Familial Colorectal Cancer, Colorectal Cancer, Iron Deficiency Anemia, and Bone Marrow Aspiration.

Anita Sultan, MD, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in internal medicine, medical oncology and hematology by the American Board of Internal Medicine, she has more than 10 years of experience treating blood diseases and various forms of cancer. She is dedicated to providing the highest quality of care and encourages patients to learn as much as they can about their disease and treatments. Dr. Sultan believes arming patients with knowledge of both conventional and complementary anticancer therapies is critical.After earning her medical degree from Hamdard College of Medicine and Dentistry in Karachi, Pakistan, Dr. Sultan completed an internal medicine residency at Liaquat National Hospital in Karachi and a three-year internal medicine residency at Texas Tech University Health Sciences Center, Lubbock, TX. She then completed a hematology and oncology fellowship also at Texas Tech, where she was named chief fellow and aided in educational program development related to sex and gender-specific health.Dr. Sultan has been published in a multitude of peer-reviewed medical journals and has presented at dozens of national and international medical conferences and symposia. She maintains a special interest in metastatic breast cancer, ovarian cancer, and lung and colorectal cancers.Dr. Sultan speaks English and Urdu. She is a member of the American College of Physicians, American Society of Clinical Oncology, and American Society of Hematology, and is a participating provider of the Atlantic Accountable Care Organization. Dr. Sultan is rated as an Experienced provider by MediFind in the treatment of Shwartzman Phenomenon. Her top areas of expertise are Thrombocytopenia, Anemia, Ovarian Cancer, and Histiocytosis.

Joshua A. Strauss, MD, is a hematologist-oncologist with Advanced Care Oncology and Hematology Associates (ACOHA), part of the Atlantic Medical Group (AMG). He is fellowship-trained and double-board-certified in medical oncology and hematology by the American Board of Internal Medicine. He has more than 15 years of experience taking care of patients with a variety of malignancies and blood disorders. Dr. Strauss especially takes pride in treating his patients with compassion and going the extra mile to deliver the highest quality of care.Dr. Strauss strives to incorporate the most up-to-date knowledge in the field with an approach geared to the needs of each individual patient. He maintains clinical interests in gastrointestinal, urologic and gynecologic cancers, as well as leukemia, lymphoma and benign blood disorders. Dr. Strauss joined ACOHA in 2015.After earning his medical degree at the Albert Einstein College of Medicine in the Bronx, where he graduated with special distinction for research in medical oncology, Dr. Strauss completed his residency in internal medicine at New York University Langone Medical Center. He then completed fellowship training in hematology/oncology at New York-Presbyterian/Columbia University Medical Center, also in NYC, where he participated in high-level research and published several peer-reviewed articles in gastrointestinal cancer.Dr. Strauss has been voted by physician colleagues as a “Top Doctor” in New Jersey Monthly magazine every year since 2020. He is a member of the American Society of Clinical Oncology and the American Society of Hematology, and is a participating provider of the Atlantic Accountable Care Organization. Dr. Strauss is rated as an Experienced provider by MediFind in the treatment of Shwartzman Phenomenon. His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Myelodysplastic Syndrome (MDS), Colorectal Cancer, and Bone Marrow Aspiration.

Maithili Rao, MD, is a senior health care entrepreneur board-certified in medical oncology and hematology by the American Board of Internal Medicine. She is affiliated with Advanced Care Oncology and Hematology Associates (ACOHA), part of Atlantic Medical Group (AMG). Her professional career includes building a worldclass oncology practice across six counties with 30 practitioners, serving as a medical executive board member at Overlook Hospital, and working as the enterprise medical director of Practice Growth and Integration at Atlantic Medical Group. Dr. Rao has championed an integrated approach to treating cancer and blood disorders, focusing on personalizing patient care, quality, and communication.At each oncology treatment site, Dr. Rao has successfully incorporated palliative care, genetic counseling, dietitians, navigators, social workers, onsite lab and pharmacy services, access to clinical trials, an infusion suite for chemotherapy and immunotherapy, and advanced molecular testing. These integrations enable her to deliver high-quality clinical care and innovative treatment protocols with a unique, holistic, patient-centered approach. She treats all forms of blood disease and cancer, with a special focus on breast cancer.Dr. Rao currently serves as the enterprise medical director of oncology and other specialties for Atlantic Health System (AHS), a multi-award-winning, seven-hospital, nonprofit, integrated health care network in northern New Jersey. AHS has over 400 sites of care, 300 physician practices, and 17,000 team members. Dr. Rao provides clinical and strategic direction for cancer care and has successfully transformed cancer care in New Jersey from a community-focused initiative to a leading oncology center that rivals prestigious competitors in New York City.Dr. Rao has been recognized by the American Cancer Society as a Medical Honoree and has been voted by her peers as New Jersey Monthly’s Top Doctor for over 13 years, among other accolades. Dr. Rao is a member of the American Society of Clinical Oncology and the American Society of Hematology, and is a participating provider of the Atlantic Accountable Care Organization. Dr. Rao is rated as an Experienced provider by MediFind in the treatment of Shwartzman Phenomenon. Her top areas of expertise are Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, Myelodysplastic Syndrome (MDS), Thrombocytopenia, and Bone Marrow Aspiration.

Noah Lindenberg is a Hematologist and a Hematologist Oncology provider in Marlton, New Jersey. Dr. Lindenberg is rated as an Experienced provider by MediFind in the treatment of Shwartzman Phenomenon. His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Familial Colorectal Cancer, and Lung Cancer. Dr. Lindenberg is currently accepting new patients.

Dr. Emmanuel Apor's desire to take care of people channeled him into the field of medicine - specifically into cancer care. Board certified in internal medicine with fellowship training in hematology-oncology, Dr. Apor strives to first understand who his patients are as people, then learn about their disease.While attaining his bachelors of art degree at Rutgers University, Dr. Apor worked at a local hospital which cemented his decision to pursue postgraduate training. He achieved his medical degree at Drexel University College of Medicine in Philadelphia and his residency at the Warren Alpert Medical School at Brown University, where he developed a passion for clinical care working with his general internist mentors and their patients.Dr. Apor attained his fellowship training in hematology-oncology at Brown University, where he served in teaching and research roles, and he held hospital appointments at both Providence Veterans Affairs Medical Center and Rhode Island Hospital. Dr. Apor is rated as an Experienced provider by MediFind in the treatment of Shwartzman Phenomenon. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Thrombocytopenia, Familial Colorectal Cancer, and Bone Marrow Aspiration.

Triple board-certified in internal medicine, hematology and medical oncology, Dr. Mohamad Cherry is medical director of Hematology at Atlantic Health System. He joins Atlantic Hematology Oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center, bringing years of clinical knowledge and expertise.With specialty training from some of the nation's most skilled clinicians, Dr. Cherry attained some of his clinical training at the leukemia department at MD Anderson and his fellowship in hematology/oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He performed two residencies - an internal medicine residency at Staten Island University Hospital and a laboratory medicine residency at the American University of Beirut Medical Center in Lebanon. Previously, Dr. Cherry attained his medical degree at Lebanese University and performed his internship at Sacre Coeur Hospital-Lebanese University. He also earned a master of science degree in clinical and translational research from University of Oklahoma College of Public Health.Dr. Cherry remains on staff as clinical associate professor of hematology/oncology at University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He is also the director of its hematology/oncology fellowship program and co-chairs the Academy of Teaching Scholars Faculty Development, Education and Mentoring Committee. Other administrative roles include co-chair of the leukemia working group at the Sarah Cannon Research Institute Blood Cancer Consortium.As a principal investigator of multiple clinical trials, Dr. Cherry has performed groundbreaking research in niche areas that include epigenetics and development of new therapeutics in relapsed and refractory blood cancers. He has developed teaching materials and book chapters, and has lectured both nationally and internationally.Dr. Cherry continues to serves as a mentor and an advisor to fellows, residents and medical students. He contributes to continuing education, public health, and professional development, and has won awards and funding for both his research and his clinical pursuits. Dr. Cherry is rated as an Experienced provider by MediFind in the treatment of Shwartzman Phenomenon. His top areas of expertise are Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Acute Myeloblastic Leukemia without Maturation, Midline Lethal Granuloma, and Bone Marrow Aspiration.

Tapati Stalam is a Cardiologist in Mullica Hill, New Jersey. Dr. Stalam has been practicing medicine for over 10 years and is rated as an Experienced provider by MediFind in the treatment of Shwartzman Phenomenon. Her top areas of expertise are Familial Neurocardiogenic Syncope, Endocarditis, Cardiomyopathy, and Fainting.

Seyoung Han, MD, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in internal medicine, hematology and medical oncology by the American Board of Internal Medicine, he has comprehensive experience and specialized training in treating blood diseases and various forms of cancer. Dr. Han’s clinical interests include lung, breast, GI, and hematologic cancers. He also participates in clinical trials as a principal investigator.Dr. Han meticulously analyzes each patient’s test results, takes detailed notes on their medical history, and performs thorough physical examinations in order to determine the most appropriate treatment options for each of his patients. He values informed decision-making to help patients maintain their quality of life. He provides patient-centered compassionate care and ensures that his patients have a full understanding of their condition and provides evidence-based treatment options.After earning his medical degree at Kyung Hee University College of Medicine in South Korea, and a compulsory three-year hitch in military service, Dr. Han performed an internal medicine residency at Saint Francis Hospital, now called Ascension Saint Francis Hospital, in Evanston, IL. After completing his residency, he served as an assistant professor and an attending physician at Southern Illinois University, then joined the bone marrow transplant program as a hospitalist and clinical instructor at Washington University in St. Louis, MO. Dr. Han then pursued advanced training with a fellowship in hematology-oncology at the University of Minnesota in Minneapolis. He was honored with an award as an outstanding fellow from the Minnesota Society of Oncology for two consecutive years. Following his fellowship, Dr. Han joined ACOHA in 2020.Fluent in English and Korean, Dr. Han is a member of the American Society of Hematology, the American Society of Clinical Oncology, the American College of Physicians, the Society of Hospital Medicine, and the Korean Medical Association. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Han is rated as an Experienced provider by MediFind in the treatment of Shwartzman Phenomenon. His top areas of expertise are Thrombocytopenia, Pleuropulmonary Blastoma, Paget Disease of the Breast, Pulmonary Embolism, and Bone Marrow Aspiration.

Domenick Randazzo is a Cardiologist and an Interventional Cardiologist in Mendham, New Jersey. Dr. Randazzo is rated as an Experienced provider by MediFind in the treatment of Shwartzman Phenomenon. His top areas of expertise are Coronary Heart Disease, Atherosclerosis, Angina, Sick Sinus Syndrome, and Heart Bypass Surgery. Dr. Randazzo is currently accepting new patients.

Tulin Budak is an Oncologist in Camden, New Jersey. Dr. Budak has been practicing medicine for over 39 years and is rated as an Advanced provider by MediFind in the treatment of Shwartzman Phenomenon. Her top areas of expertise are Multiple Myeloma, Chronic Lymphocytic Leukemia (CLL), Deep Vein Thrombosis, Bone Marrow Transplant, and Bone Marrow Aspiration.

Manish Malik is a Cardiologist in Woodbury Heights, New Jersey. Dr. Malik is rated as an Experienced provider by MediFind in the treatment of Shwartzman Phenomenon. His top areas of expertise are Necrosis, Coronary Heart Disease, Atherosclerosis, Heart Valve Repair, and Aortic Valve Replacement. Dr. Malik is currently accepting new patients.